Results 221 to 230 of about 57,910 (287)
Neuroinflammatory diseases of the CNS are difficult to diagnose, and current CSF biomarkers lack sensitivity across conditions. Soluble CD27 (sCD27), a marker of adaptive immune activation, has emerged as a promising candidate, but its clinical utility remains uncertain.
Nadia Damholt Savino +5 more
wiley +1 more source
Handgrip strength and the Index of pulmonary dysfunction: Practical screening tools for cough dysfunction in huntington's disease. [PDF]
Konvalinkova R +6 more
europepmc +1 more source
Graphical abstract illustrating the in vitro and in vivo experimental workflow used to compare BPM31510, a nanoliposomal formulation of oxidized CoQ10, with conventional CoQ10. Chemically induced CoQ‐deficient SH‐SY5Y cells, CoQ‐deficient patient fibroblasts, and C57BL/6J mice receiving oral CoQ10 or intraperitoneal BPM31510 were subjected to plasma ...
Juan J. Aristizabal‐Henao +18 more
wiley +1 more source
Neural Mechanisms of Object Location Memory in Huntington's Disease. [PDF]
Glikmann-Johnston Y +4 more
europepmc +1 more source
Correction: Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion. [PDF]
Kodam P +5 more
europepmc +1 more source
Dysphagia in Huntington's Disease: An Evaluation of Swallowing Disturbance across the HD-ISS Staging Spectrum. [PDF]
Kaur J +3 more
europepmc +1 more source
Aberrant expression of the MID1 protein in neurons of Huntington's disease brain. [PDF]
Geraci A +3 more
europepmc +1 more source
Late-Onset Huntington's Disease: A Case Report and Literature Review. [PDF]
Gonçalves C +4 more
europepmc +1 more source

